2022
National outcomes following benign cardiac tumor resection: A critical sex‐based disparity
Newell P, Zogg CK, Kusner J, Hirji S, Kerolos M, Kaneko T. National outcomes following benign cardiac tumor resection: A critical sex‐based disparity. Journal Of Cardiac Surgery 2022, 37: 2653-2660. PMID: 35662249, DOI: 10.1111/jocs.16654.Peer-Reviewed Original ResearchConceptsComposite morbiditySurgical resectionIndependent predictorsMultivariable analysisVentricular tumorsFemale sexBenign primary cardiac tumorsCardiac tumor resectionLower comorbidity burdenPrimary cardiac tumorsNationwide Readmissions DatabaseMajority of patientsIntra-atrial septumNational outcomesSex-based disparitiesComorbidity burdenCardiac tumorsPrimary outcomeFemale patientsMean ageVentricular septumPrimary diagnosisRight atriumTumor locationTumor resection
2017
Epidemiology of malignant cutaneous granular cell tumors: A US population-based cohort analysis using the Surveillance, Epidemiology, and End Results (SEER) database
Mirza FN, Tuggle CT, Zogg CK, Mirza HN, Narayan D. Epidemiology of malignant cutaneous granular cell tumors: A US population-based cohort analysis using the Surveillance, Epidemiology, and End Results (SEER) database. Journal Of The American Academy Of Dermatology 2017, 78: 490-497.e1. PMID: 28989104, PMCID: PMC5815907, DOI: 10.1016/j.jaad.2017.09.062.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overBlack or African AmericanChildFemaleGranular Cell TumorHumansIncidenceKaplan-Meier EstimateKidney NeoplasmsMaleMiddle AgedNeoplasm StagingPancreatic NeoplasmsResidence CharacteristicsRetrospective StudiesSEER ProgramSex FactorsSkin NeoplasmsSurvival RateUnited StatesWhite PeopleYoung AdultConceptsDisease-specific survivalCutaneous granular cell tumorsPopulation-based cohort analysisEnd Results (SEER) databaseMedian survival timeGranular cell tumorSurgical resectionResults databaseCell tumorsCohort analysisSurvival timeCox proportional hazards regressionPoor disease-specific survivalRisk-adjusted associationHigh-risk patientsEnd Results (SEER) dataProportional hazards regressionSingle-institution studyAdvanced cancer stageRisk-adjusted modelsDSS ratesOverall survivalPatient characteristicsSubstantial morbiditySecondary malignancies